The Coming of Age of the Class III Antiarrhythmic Principle: Retrospective and Future Trends
- 1 August 1996
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (4) , 17-27
- https://doi.org/10.1016/s0002-9149(96)00449-3
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Antiarrhythmic drugsCurrent Opinion in Cardiology, 1993
- Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillationJournal of the American College of Cardiology, 1992
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985The American Journal of Cardiology, 1991
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Comparative mechanisms of action of antiarrhythmic drugsAmerican Heart Journal, 1974
- Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular MuscleCirculation Research, 1971
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970